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Objectives:  
To analyse the clinicopathological and immunohistochemical features of 
Rhabdomyosarcomas (RMS) in adult and pediatric population and to identify PAX3/7-
FOXO1 translocation in alveolar and unclassifiable RMS. 
Methods:  
A prospective and retrospective analysis of immunomorphological features, PAX3/7-
FOXO1 translocation and clinical outcome for 71 subjects was done from Jan 2012 to 
Mar 2016.  Molecular analysis for PAX3/7-FOXO1 translocation was done by PCR.  
Pearson’s Chi square test, Kaplan Meier’s test and univariate & multivariate analyses 
were  used for analysis.  
Results: 
 Patient age ranged from 2 months-65 years, predominantly males with equal              
distribution of embryonal and alveolar (36.62%) subtypes. 
 Head & neck (28.17%) was the common site.  
 Most of them were >5cm and belonged to stage 4,  lymphnode being the commonest 
metastatic site.  
 Tumour necrosis and reparative changes were the common postchemotherapy 
changes. Strong immunostaining for myogenin was seen in ARMS. 
 Metastasis and recurrence were common in ARMS, the unfavourable sites with 
higher rate of metastasis.  
 The overall survival rate was 93.7% with a median survival duration of 86 days (14-
158 days) during the followup period of 2 days to 40 months. The overall DFS was 
28 days (77-496 days).  The DFS  was 312 days (132-491 days) for alveolar RMS. 
The median DFS was 83 days (20.5-145.4 days) for 12 cases which had recurrence. 
 Translocation (PAX3/FOXO1) was found only in one typical ARMS. 
Conclusions: 
    Patients were predominantly males, <10 years. 
    Strong(3+) myogenin staining was found in ARMS, which also showed increased 
       risk  of metastasis and recurrence. 
    Unfavourable site predicted poor outcome. 
    PAX3/FOXO1 translocation in only one case could be explained by a possibly  
      low  frequency of translocation in the Indian  population. 
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